Clinical Trial Update: Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on rivaroxaban for patients with atrial fibrillation and coronary artery disease undergoing percutaneous coronary intervention; cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Artery Disease

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Beijing Anzhen Hospital | Conditions: Atrial Fibrillation | Phase 4 | Status: UNKNOWN